Literature DB >> 1985928

Amino acid sequences of the two subunits of a phospholipase A2 inhibitor from the blood plasma of Trimeresurus flavoviridis. Sequence homologies with pulmonary surfactant apoprotein and animal lectins.

S Inoue1, H Kogaki, K Ikeda, Y Samejima, T Omori-Satoh.   

Abstract

Phospholipase A2 inhibitor (PLI), purified from the blood plasma of the Habu snake (Trimeresurus flavoviridis), was separated into two distinct subunits, PLI-A and PLI-B. These subunits were shown to be glycoproteins with molecular weights of around 21,000-22,000. When they were deglycosylated chemically with trifluoromethanesulfonic acid, the molecular weights were found to be 17,000. Their amino acid sequences were determined by alignment of peptides obtained by lysyl endopeptidase digestion and Staphylococcus aureus V8 protease digestion. PLI-A and PLI-B were each composed of 147 amino acid residues with one residue, Asn103, being for N-linked glycosylation, and the molecular weights of their protein portions were calculated to be 16,368 and 16,408, respectively. Each subunit contained four cysteine residues, all of which exist in disulfide linkages (Cys64-Cys141 and Cys119-Cys133). The sequences of PLI-A and PLI-B showed 89.9% homology to each other. When the sequences were compared with those of lipocortins, no significant homologies were detected. But the sequences were significantly homologous to those of COOH-terminal carbohydrate recognition portions of pulmonary surfactant apoprotein and animal lectins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985928

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Purification and inhibitory profile of phospholipase A2 inhibitors from Australian elapid sera.

Authors:  P G Hains; K W Broady
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Purification and characterization of three distinct types of phospholipase A2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffii siniticus.

Authors:  N Ohkura; H Okuhara; S Inoue; K Ikeda; K Hayashi
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

3.  Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper.

Authors:  S Lizano; B Lomonte; J W Fox; J M Gutiérrez
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.

Authors:  L Arbibe; K Koumanov; D Vial; C Rougeot; G Faure; N Havet; S Longacre; B B Vargaftig; G Béréziat; D R Voelker; C Wolf; L Touqui
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

5.  Purification, characterization and cDNA cloning of a phospholipase A2 inhibitor from the serum of the non-venomous snake Elaphe quadrivirgata.

Authors:  K Okumura; K Masui; S Inoue; K Ikeda; K Hayashi
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

6.  Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties.

Authors:  S Lizano; Y Angulo; B Lomonte; J W Fox; G Lambeau; M Lazdunski; J M Gutiérrez
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

7.  Interisland mutation of a novel phospholipase A2 from Trimeresurus flavoviridis venom and evolution of Crotalinae group II phospholipases A2.

Authors:  Takahito Chijiwa; Sachiko Hamai; Shoji Tsubouchi; Tomohisa Ogawa; Masanobu Deshimaru; Naoko Oda-Ueda; Shosaku Hattori; Hiroshi Kihara; Susumu Tsunasawa; Motonori Ohno
Journal:  J Mol Evol       Date:  2003-11       Impact factor: 2.395

8.  Identification of the B subtype of gamma-phospholipase A2 inhibitor from Protobothrops flavoviridis serum and molecular evolution of snake serum phospholipase A2 inhibitors.

Authors:  Shuhei So; Takahito Chijiwa; Naoki Ikeda; Ikuo Nobuhisa; Naoko Oda-Ueda; Shosaku Hattori; Motonori Ohno
Journal:  J Mol Evol       Date:  2008-03-04       Impact factor: 2.395

Review 9.  Endogenous phospholipase A2 inhibitors in snakes: a brief overview.

Authors:  Patrícia Cota Campos; Lutiana Amaral de Melo; Gabriel Latorre Fortes Dias; Consuelo Latorre Fortes-Dias
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-12-21

Review 10.  Alpha-type phospholipase A2 inhibitors from snake blood.

Authors:  Norival A Santos-Filho; Claudia T Santos
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.